Altamira Therapeutics Ltd.

Industry

  • Biotechnology
    • Antisense, Oligonucleotides
  • Pharmaceuticals
    • OTC, Consumer
    • Drug Delivery

Other Names/Subsidiaries

  • Auris Medical
  • Auris Medical Holding
  • Trasir Therapeutics
  • Zilentin
See more in Biomedtracker

Latest on Altamira Therapeutics Ltd.

Scrip

Deal Watch: Novo Nordisk, IMMvention To Partner On Sickle Cell Disease

 
• By Joseph Haas, Dexter Jie Yan, Xu Hu, and Vibha Ravi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novo Nordisk, IMMvention Collaboration

Scrip

Asia Deal Watch: EpimAb Licenses Bispecific Antibody To Newly Formed Vignette

 
• By Joseph Haas, Dexter Jie Yan, Xu Hu, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Vignette Gets Rights To BCMA×CD3 Bispec

Scrip

Deal Watch: Gilead Acquires Xilio’s IL-12 Activating Candidate

 
• By Joseph Haas and Alaric DeArment

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets Xilio’s Phase I Cancer Drug

Scrip

Deal Watch: Novartis, Ionis Team Up Again In Cardiovascular Disease

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis And Ionis Build On Earlier Akc